vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $57.3M, roughly 1.3× RHYTHM PHARMACEUTICALS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -83.0%, a 91.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 10.6%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
BFS vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $57.3M |
| Net Profit | $6.5M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 65.4% | -82.2% |
| Net Margin | 8.7% | -83.0% |
| Revenue YoY | 10.6% | 36.9% |
| Net Profit YoY | -19.6% | -9.6% |
| EPS (diluted) | $0.15 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $57.3M | ||
| Q3 25 | $72.0M | $51.3M | ||
| Q2 25 | $70.8M | $48.5M | ||
| Q1 25 | $71.9M | $32.7M | ||
| Q4 24 | $67.9M | $41.8M | ||
| Q3 24 | $67.3M | $33.3M | ||
| Q2 24 | $66.9M | $29.1M | ||
| Q1 24 | $66.7M | $26.0M |
| Q4 25 | $6.5M | $-47.5M | ||
| Q3 25 | $10.5M | $-52.9M | ||
| Q2 25 | $10.7M | $-46.6M | ||
| Q1 25 | $9.8M | $-49.5M | ||
| Q4 24 | $8.1M | $-43.3M | ||
| Q3 24 | $14.5M | $-43.6M | ||
| Q2 24 | $14.4M | $-32.3M | ||
| Q1 24 | $13.6M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | 73.6% | 88.5% | ||
| Q2 24 | 74.2% | 89.9% | ||
| Q1 24 | 72.8% | 89.2% |
| Q4 25 | 65.4% | -82.2% | ||
| Q3 25 | 69.1% | -102.6% | ||
| Q2 25 | 68.7% | -93.4% | ||
| Q1 25 | 66.5% | -143.7% | ||
| Q4 24 | 82.9% | -98.6% | ||
| Q3 24 | 72.8% | -132.0% | ||
| Q2 24 | 75.0% | -139.2% | ||
| Q1 24 | 72.4% | -538.7% |
| Q4 25 | 8.7% | -83.0% | ||
| Q3 25 | 14.6% | -103.1% | ||
| Q2 25 | 15.1% | -96.1% | ||
| Q1 25 | 13.6% | -151.4% | ||
| Q4 24 | 11.9% | -103.6% | ||
| Q3 24 | 21.5% | -131.2% | ||
| Q2 24 | 21.6% | -110.9% | ||
| Q1 24 | 20.4% | -544.4% |
| Q4 25 | $0.15 | $-0.73 | ||
| Q3 25 | $0.32 | $-0.82 | ||
| Q2 25 | $0.33 | $-0.75 | ||
| Q1 25 | $0.29 | $-0.81 | ||
| Q4 24 | $0.22 | $-0.71 | ||
| Q3 24 | $0.48 | $-0.73 | ||
| Q2 24 | $0.48 | $-0.55 | ||
| Q1 24 | $0.45 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $388.9M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $139.1M |
| Total Assets | $2.2B | $480.2M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $388.9M | ||
| Q3 25 | $11.8M | $416.1M | ||
| Q2 25 | $5.3M | $291.0M | ||
| Q1 25 | $6.5M | $314.5M | ||
| Q4 24 | $10.3M | $320.6M | ||
| Q3 24 | $7.2M | $298.4M | ||
| Q2 24 | $6.9M | $319.1M | ||
| Q1 24 | $7.1M | $201.2M |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $455.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $307.8M | $139.1M | ||
| Q3 25 | $316.6M | $148.8M | ||
| Q2 25 | $322.4M | $-11.9M | ||
| Q1 25 | $328.4M | $18.9M | ||
| Q4 24 | $335.8M | $21.7M | ||
| Q3 24 | $341.8M | $11.2M | ||
| Q2 24 | $345.7M | $39.3M | ||
| Q1 24 | $347.1M | $61.6M |
| Q4 25 | $2.2B | $480.2M | ||
| Q3 25 | $2.2B | $506.9M | ||
| Q2 25 | $2.1B | $372.7M | ||
| Q1 25 | $2.1B | $386.7M | ||
| Q4 24 | $2.1B | $392.3M | ||
| Q3 24 | $2.1B | $363.6M | ||
| Q2 24 | $2.1B | $381.8M | ||
| Q1 24 | $2.0B | $258.7M |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $-25.4M | ||
| Q3 25 | $20.6M | $-26.6M | ||
| Q2 25 | $26.6M | $-23.3M | ||
| Q1 25 | $30.4M | $-40.4M | ||
| Q4 24 | $121.2M | $-18.8M | ||
| Q3 24 | $26.5M | $-25.2M | ||
| Q2 24 | $32.1M | $-29.1M | ||
| Q1 24 | $33.8M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-28.3M | — | ||
| Q2 24 | $-12.5M | — | ||
| Q1 24 | $-11.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -42.1% | — | ||
| Q2 24 | -18.7% | — | ||
| Q1 24 | -17.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 81.5% | — | ||
| Q2 24 | 66.7% | — | ||
| Q1 24 | 68.3% | — |
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
